Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amniotic membrane surgery.

K C Sippel1, J J Ma, C S Foster

  • 1Cornea Service, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114, USA.

Current Opinion in Ophthalmology
|August 17, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.

British journal of cancer·2014
Same author

Association between DNA methylation of HSPB1 and death in low Gleason score prostate cancer.

Prostate cancer and prostatic diseases·2012
Same author

Atopic keratoconjunctivitis.

Ocular immunology and inflammation·2012
Same author

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer.

British journal of cancer·2012
Same author

Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort.

British journal of cancer·2012
Same author

Difluprednate for inflammatory eye disorders.

Drugs of today (Barcelona, Spain : 1998)·2011
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Human amniotic membrane transplantation (AMT) shows promise for various eye conditions, aiding epithelialization and reducing inflammation. Further controlled trials are needed to confirm its superiority over existing treatments.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Biomaterials

Background:

  • Human amniotic membrane (AM) possesses anti-adhesive properties.
  • AM is believed to promote epithelialization and reduce inflammation, neovascularization, and fibrosis.
  • AM has a unique three-layered structure: epithelium, basement membrane, and avascular stroma.

Purpose of the Study:

  • To review the current ophthalmic applications of amniotic membrane transplantation (AMT).
  • To highlight the potential benefits of AMT in treating various ocular surface diseases.
  • To identify areas where further clinical evidence is required.

Main Methods:

  • Review of existing literature on amniotic membrane transplantation in ophthalmology.
  • Analysis of studies detailing the use of AM in corneal reconstruction, stem cell therapy, and conjunctival surface repair.

Related Experiment Videos

  • Examination of novel applications, including ex vivo cell culture.

    • Main Results:

    • AMT is effective for persistent epithelial defects, sterile corneal ulcerations, and partial limbal stem cell deficiency.
    • AMT can be used adjunctively with limbal stem cell transplantation (LSCT) or as an alternative to conjunctival autografting.
    • AM serves as a matrix for ex vivo cultivation of limbal epithelial cells.

    Conclusions:

    • Amniotic membrane transplantation is a versatile therapeutic option for a growing range of ophthalmic conditions.
    • While promising, the superiority of AMT requires validation through controlled clinical trials.
    • Further research is essential to establish definitive treatment guidelines and comparative efficacy.